Olga Rass1, Rebecca L Schacht2, Katherine Buckheit1, Matthew W Johnson1, Eric C Strain1, Miriam Z Mintzer1. 1. Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. 2. Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. Electronic address: rschacht@umbc.edu.
Abstract
OBJECTIVE: Working memory impairment in individuals with chronic opioid dependence can play a major role in cognitive and treatment outcomes. Cognitive training targeting working memory shows promise for improved function in substance use disorders. To date, cognitive training has not been incorporated as an adjunctive treatment for opioid dependence. METHODS:Methadone maintenance patients were randomly assigned to experimental (n=28) or active control (n=28) 25-session computerized training and run in parallel. Cognitive and drug use outcomes were assessed before and after training. RESULTS: Participants in the experimental condition showed performance improvements on two of four working memory measures, and both groups improved on a third measure of working memory performance. Less frequent drug use was found in the experimental group than in the control group post-training. In contrast to previous findings with stimulant users, no significant effect of working memory training on delay discounting was found using either hypothetical or real rewards. There were no group differences on working memory outcome measures that were dissimilar from the training tasks, suggesting that another mechanism (e.g., increased distress tolerance) may have driven drug use results. CONCLUSIONS:Working memory training improves performance on some measures of working memory in methadone maintenance patients, and may impact drug use outcomes. Working memory training shows promise in patients with substance use disorders; however, further research is needed to understand the mechanisms through which performance is improved and drug use outcomes are impacted.
RCT Entities:
OBJECTIVE:Working memory impairment in individuals with chronic opioid dependence can play a major role in cognitive and treatment outcomes. Cognitive training targeting working memory shows promise for improved function in substance use disorders. To date, cognitive training has not been incorporated as an adjunctive treatment for opioid dependence. METHODS:Methadone maintenance patients were randomly assigned to experimental (n=28) or active control (n=28) 25-session computerized training and run in parallel. Cognitive and drug use outcomes were assessed before and after training. RESULTS:Participants in the experimental condition showed performance improvements on two of four working memory measures, and both groups improved on a third measure of working memory performance. Less frequent drug use was found in the experimental group than in the control group post-training. In contrast to previous findings with stimulant users, no significant effect of working memory training on delay discounting was found using either hypothetical or real rewards. There were no group differences on working memory outcome measures that were dissimilar from the training tasks, suggesting that another mechanism (e.g., increased distress tolerance) may have driven drug use results. CONCLUSIONS:Working memory training improves performance on some measures of working memory in methadone maintenance patients, and may impact drug use outcomes. Working memory training shows promise in patients with substance use disorders; however, further research is needed to understand the mechanisms through which performance is improved and drug use outcomes are impacted.
Authors: C B Eap; M Bourquin; J Martin; J Spagnoli; S Livoti; K Powell; P Baumann; J Déglon Journal: Drug Alcohol Depend Date: 2000-12-22 Impact factor: 4.492
Authors: Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt Journal: Subst Abus Date: 2009 Oct-Dec Impact factor: 3.716
Authors: Kathleen M Carroll; Charla Nich; Elise E DeVito; Julia M Shi; Mehmet Sofuoglu Journal: J Clin Psychiatry Date: 2018 Jan/Feb Impact factor: 4.384
Authors: Sarah E Snider; Harshawardhan U Deshpande; Jonathan M Lisinski; Mikhail N Koffarnus; Stephen M LaConte; Warren K Bickel Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2017-11-21
Authors: Warren K Bickel; Alexandra M Mellis; Sarah E Snider; Lara Moody; Jeffrey S Stein; Amanda J Quisenberry Journal: Curr Treat Options Psychiatry Date: 2016-07-02
Authors: Brian D Kiluk; Matthew B Buck; Kathleen A Devore; Theresa A Babuscio; Charla Nich; Kathleen M Carroll Journal: J Subst Abuse Treat Date: 2016-08-10
Authors: Mary M Sweeney; Olga Rass; Cara DiClemente; Rebecca L Schacht; Hoa T Vo; Marc J Fishman; Jeannie-Marie S Leoutsakos; Miriam Z Mintzer; Matthew W Johnson Journal: J Child Adolesc Subst Abuse Date: 2018-04-10
Authors: Robert Miranda; Stephanie E Wemm; Hayley Treloar Padovano; Ryan W Carpenter; Noah N Emery; Joshua C Gray; Ethan H Mereish Journal: Clin Psychol Sci Date: 2019-09-01
Authors: Mary M Sweeney; Olga Rass; Patrick S Johnson; Eric C Strain; Meredith S Berry; Hoa T Vo; Marc J Fishman; Cynthia A Munro; George W Rebok; Miriam Z Mintzer; Matthew W Johnson Journal: Exp Clin Psychopharmacol Date: 2016-10 Impact factor: 3.157